Although many review articles have focused on FoxP3+CD25+CD4+ Tregs [9, 29, 30], a new review is necessary for appraising recent research advances in FoxP3+CD25+CD4+ Tregs after stroke. This evidence concerns the gene CD4 and stroke disorder.